Topics
Pediatric CNS tumors | Outcomes | Autologous Hematopoietic Stem Cell Transplant
Home > Publications > Topics > Pediatric CNS tumors > Outcomes > Autologous Hematopoietic Stem Cell Transplant
*Knight TE, Broglie L, Sharma A, Qayed M, Yanik GA.
Why
are Higher CD34+ Cell Doses Associated with Improved Outcomes
among Pediatric Patients Undergoing Autologous Hematopoietic Stem
Cell Transplant for Central Nervous System Tumors - But Not for
High-Risk Neuroblastoma?
Pediatr
Hematol Oncol. 2024 Nov 5:1-5. doi:
10.1080/08880018.2024.2420924. PMID:
39501613. Observational study˰
ˍ